Genetically engineered mice: Model systems for left ventricular failure

Journal of Cardiac Failure

Volumn 4, Issue 4, 1998, Pages 349-361

  Kadambi, Vivek J ^a   Kranias, Evangelia G ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ADENOSINE TRIPHOSPHATASE (CALCIUM); ALPHA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; CALCINEURIN; CALPHOBINDIN II; CALSEQUESTRIN; GROWTH FACTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; PHOSPHOLAMBAN; PROTEIN KINASE C; PROTEIN SERINE THREONINE KINASE; TRANSCRIPTION FACTOR; TROPOMODULIN; TROPOMYOSIN; TROPONIN C;

ANIMAL MODEL; GENE EXPRESSION; GENE TARGETING; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE CONTRACTILITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SARCOPLASMIC RETICULUM; TRANSGENIC MOUSE;

EID: 0032422588     PISSN: 10719164     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-9164(98)90241-X     Document Type: Review

References (59)

1. Colucci WS, Braundwald E: Pathophysiology of Heart Failure. Heart Disease; A Textbook of Cardiovascular Medicine (ed 5) Saunders, Philadelphia, 1997, pp 394-420
2. Opie LH: The Heart: Physiology and Metabolism, Raven Press, New York, 1991
3. Kadambi VJ, Kranias EG: Phospholamban: a protein coming of age. Biochem Biophys Res Commun 1997;239:1-5
4. Gordon JW, Scangos GA, Plotkin DJ, Barbosa JA, Ruddle FH: Genetic transformation of mouse embryos by micro-injection of purified DNA. Proc Natl Acad Sci USA 1980; 77:7380-4
5. Gordon JW, Ruddle FH: Integration and stable germ line transmission of genes injected into mouse pronuclei. Science 1981;214:1244-6
6. Hogan B, Constantini F, Lacey E: Manipulating the Mouse Embryo, Cold Spring Harbor Laboratory Press, New York, 1986
7. Capecchi MR: Targeted gene replacement. Sci Am 1994; 270:52-9
8. Subramaniam A, Jones WK, Gulick J, Wert S, Neumann J, Robbins J: Tissue-specific regulation of the alpha-myosin heavy chain gene promoter in transgenic mice. J Biol Chem 1991;266:24613-20
9. Jones WK, Grupp IL, Doetschman T, Grupp G, Osinska H, Hewett TE, Boivin G, Gulick J, Ng WA, Robbins J: Ablation of the murine alpha myosin heavy chain gene leads to dosage effects and functional deficits in the heart. J Clin Invest 1996;98:1906-17
10. Vikstrom KL, Leinwand LA: Contractile protein mutations and heart disease. Curr Opin Cell Biol 1996;8:97-105
11. Geisterfer-Lowrance AA, Christe M, Conner DA, Ingwall JS, Schoen FJ, Seidman CE, Seidman JG: A mouse model of familial hypertrophic cardiomyopathy. Science 1996; 272:731-4
12. Cummins P, Russell G: A comparison of myosin light chain subunits in the atria and ventricles of mammals. Comp Biochem Physiol 1986;84:343-8
13. Palermo J, Gulick J, Colbert M, Fewell J, Robbins J: Transgenic remodeling of the contractile apparatus in the mammalian heart. Circ Res 1996;78:504-9
14. Fewell JG, Hewett TE, Sanbe A, Klevitsky R, Hayes E, Warshaw D, Maughan D, Robbins J: Functional significance of cardiac myosin essential light chain isoform switching in transgenic mice. J Clin Invest 1998;101: 2630-9
15. Chen J, Kubalak SW, Minamisawa S, Price RL, Becker KD, Hickey R, Ross J, Jr., Chien KR: Selective requirement of myosin light chain 2v in embryonic heart function. J Biol Chem 1998;273:1252-6
16. Kumar A, Crawford K, Close L, Madison M, Lorenz J, Doetschman T, Pawlowski S, Duffy J, Neumann J, Robbins J, Boivin GP, BA OT, Lessard JL: Rescue of cardiac alpha-actin-deficient mice by enteric smooth muscle gamma-actin. Proc Natl Acad Sci USA 1997;94:4406-11
17. Muthuchamy M, Rethinasamy P, Wieczorek D: Tropomyosin function and structure: new insights. Trends Cardiovasc Med 1997;7:124-8
18. Blanchard EM, Iizuka K, Christe M, Conner DA, Geisterfer-Lowrance A, Schoen FJ, Maughan DW, Seidman CE, Seidman JG: Targeted ablation of the murine alpha-tropomyosin gene. Circ Res 1997;81:1005-10
19. Rethinasamy P, Muthuchamy M, Hewett T, Boivin G, Wolska BM, Evans C, Solaro RJ, Wieczorek DF: Molecular and physiological effects of alpha-tropomyosin ablation in the mouse. Circ Res 1998;82:116-23
20. Muthuchamy M, Grupp IL, Grupp G, O'Toole B, Kier AB, Boivin GP, Neumann J, Wieczorek DF: Molecular and physiological effects of overexpressing striated muscle beta-tropomyosin in the adult murine heart. J Biol Chem 1995;270:30593-603
21. Metzger JM, Parmacek MS, Barr E, Pasyk K, Lin WI, Cochrane KL, Field LJ, Leiden JM: Skeletal troponin C reduces contractile sensitivity to acidosis in cardiac myocytes from transgenic mice. Proc Natl Acad Sci USA 1993;90:9036-40
22. Sussman MA, Sakhi S, Barrientos P, Ito M, Kedes LS: Tropomodulin in rat cardiac muscle. Localization of protein is independent of messenger RNA distribution during myofibrillar development. Circ Res 1994;75:221-32
23. Sussman MA, Welch S, Cambon N, Klevitsky R, Hewett TE, Price R, Witt SA, Kimball TR: Myofibril degeneration caused by tropomodulin overexpression leads to dilated cardiomyopathy in juvenile mice. J Clin Invest 1998;101: 51-61
24. Arber S, Caroni PS: Specificity of single LIM motifs in targeting and LIM/LIM interactions in situ. Genes Dev 1996;10:289-300
25. Arber S, Hunter JJ, Ross J, Jr., Hongo M, Sansig G, Borg J, Perriard JC, Chien KR, Caroni P: MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure. Cell 1997; 88:393-403
26. Franzini-Armstrong C, Jorgensen AO: Structure and development of E-C coupling units in skeletal muscle. Annu Rev Physiol 1994;56:509-34
27. He H, Giordano FJ, Hilal-Dandan R, Choi DJ, Rockman HA, McDonough PM, Bluhm WF, Meyer M, Sayen MR, Swanson E, Dillmann WH: Overexpression of the rat sarcoplasmic reticulum Ca2+ ATPase gene in the heart of transgenic mice accelerates calcium transients and cardiac relaxation. J Clin Invest 1997;100:380-9
28. Luo W, Grupp IL, Harrer J, Ponniah S, Grupp G, Duffy JJ, Doetschman T, Kranias EG: Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation. Circ Res 1994;75:401-9
29. Luo W, Wolska BM, Grupp IL, Harrer JM, Haghighi K, Ferguson DG, Slack JP, Grupp G, Doetschman T, Solaro RJ, Kranias EG: Phospholamban gene dosage effects in the mammalian heart. Circ Res 1996;78:839-47
30. Kadambi VJ, Ponniah S, Harrer JM, Hoit BD, Dorn GW, 2nd, Walsh RA, Kranias EG: Cardiac-specific overexpression of phospholamban alters calcium kinetics and resultant cardiomyocyte mechanics in transgenic mice. J Clin Invest 1996;97:533-9
31. Yano K, Zarain-Herzberg A: Sarcoplasmic reticulum calsequestrins: structural and functional properties. Mol Cell Biochem 1994;135:61-70
32. 2+ signaling in transgenic mouse cardiac myocytes overexpressing calsequestrin. J Clin Invest 1998;101: 1385-93
33. Sato Y, Ferguson DG, Sako H, Dorn II GW, Kadambi VJ, Yatani A, Hoit BD, Walsh RA, Kranias EG: Cardiac-specific overexpression of mouse cardiac calsequestrin is associated with depressed cardiovascular function and hypertrophy in transgenic mice. J Biol Chem 1998;273:28470-7
34. Brodde OE: Beta-adrenoceptors in cardiac disease. Pharmacol Ther 1993;60:405-30
35. Milano CA, Allen LF, Rockman HA, Dolber PC, McMinn TR, Chien KR, Johnson TD, Bond RA, Lefkowitz RJ: Enhanced myocardial function in transgenic mice overexpressing the beta 2-adrenergic receptor. Science 1994;264: 582-6
36. Turki J, Lorenz JN, Green SA, Donnelly ET, Jacinto M, Liggett SB: Myocardial signaling defects and impaired cardiac function of a human beta 2-adrenergic receptor polymorphism expressed in transgenic mice. Proc Natl Acad Sci USA 1996;93:10483-8
37. Terzic A, Puceat M, Vassort G, Vogel SM: Cardiac alpha 1-adrenoceptors: an overview. Pharmacol Rev 1993;45: 147-75
38. Milano CA, Dolber PC, Rockman HA, Bond RA, Venable ME, Allen LF, Lefkowitz RJ: Myocardial expression of a constitutively active alpha 1B-adrenergic receptor in transgenic mice induces cardiac hypertrophy. Circ Res 1994; 75:870-8
39. Akhter SA, Milano CA, Shotwell KF, Cho MC, Rockman HA, Lefkowitz RJ, Koch WJ: Transgenic mice with cardiac overexpression of alpha1B-adrenergic receptors. In vivo alpha 1-adrenergic receptor-mediated regulation of beta-adrenergic signaling. J Biol Chem 1997;272:21253-9
40. Gunteski-Hamblin AM, Song G, Walsh RA, Frenzke M, Boivin GP, Dorn GW II, Kaetzel MA, Horseman ND, Dedman JR: Annexin VI overexpression targeted to heart alters cardiomyocyte function in transgenic mice. Am J Physiol 1996;270:H1091-1100
41. Freedman NJ, Liggett SB, Drachman DE, Pei G, Caron MG, Lefkowitz RJ: Phosphorylation and desensitization of the human beta 1-adrenergic receptor. Involvement of G protein-coupled receptor kinases and cAMP-dependent protein kinase. J Biol Chem 1995;270:17953-61
42. Koch WJ, Rockman HA, Samama P, Hamilton RA, Bond RA, Milano CA, Lefkowitz RJ: Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a βARK inhibitor. Science 1995;268:1350-3
43. Jaber M, Koch WJ, Rockman H, Smith B, Bond RA, Sulik KK, Ross J, Jr., Lefkowitz RJ, Caron MG, Giros B: Essential role of beta-adrenergic receptor kinase 1 in cardiac development and function. Proc Natl Acad Sci USA 1996; 93:12974-9
44. S alpha overexpression. Circ Res 1996;78:517-24
45. D'Angelo D, Sakata Y, Lorenz JN, Boivin GP, Walsh RA, Liggett SB, Dorn GW, II: Transgenic Gαq overexpression induces cardiac contractile failure in mice. Proc Natl Acad Sci USA 1997;94:8121-6
46. Steinberg SF, Goldberg M, Rybin VO: Protein kinase C isoform diversity in the heart. J Mol Cell Cardiol 1995;27: 141-53
47. Wakasaki H, Koya D, Schoen FJ, Jirousek MR, Ways DK, Hoit BD, Walsh RA, King GL: Targeted overexpression of protein kinase C β2 isoform in myocardium causes cardiomyopathy. Proc Natl Acad Sci USA 1997;94:9320-5
48. Hefti MA, Harder BA, Eppenberger HM, Schaub MC: Signaling pathways in cardiac myocyte hypertrophy. J Mol Cell Cardiol 1997;29:2873-92
49. Hunter JJ, Tanaka N, Rockman HA, Ross J, Jr., Chien KR: Ventricular expression of a MLC-2v-ras fusion gene induces cardiac hypertrophy and selective diastolic dysfunction in transgenic mice. J Biol Chem 1995;270:23173-8
50. Levine B, Kalman J, Mayer L, Fillit HM, Packer M: Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990;323: 236-41
51. Kubota T, McTiernan CF, Frye CS, Slawson SE, Lemster BH, Koretsky AP, Demetris AJ, Feldman AM: Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-alpha. Circ Res 1997;81:627-35
52. Olson EN, Srivastava D: Molecular pathways controlling heart development. Science 1996;272:671-6
53. Miner JH, Miller JB, Wold BJ: Skeletal muscle phenotypes initiated by ectopic MyoD in transgenic mouse heart. Development 1992;114:853-60
54. Edwards JG, Lyons GE, Micales BK, Malhotra A, Factor S, Leinwand LA: Cardiomyopathy in transgenic myf5 mice. Circ Res 1996;78:379-87
55. Sucov HM, Dyson E, Gumeringer CL, Price J, Chien KR, Evans RM: RXR alpha mutant mice establish a genetic basis for vitamin A signaling in heart morphogenesis. Genes Dev 1994;8:1007-18
56. Colbert MC, Hall DG, Kimball TR, Witt SA, Lorenz JN, Kirby ML, Hewett TE, Klevitsky R, Robbins J: Cardiac compartment-specific overexpression of a modified retinoic acid receptor produces dilated cardiomyopathy and congestive heart failure in transgenic mice. J Clin Invest 1997;100:1958-68
57. Molkentin JD, Lu JR, Antos CL, Markham B, Richardson J, Robbins J, Grant SR, Olson EN: A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 1998;93:215-28
58. Herzig TC, Jobe SM, Aoki H, Molkentin JD, Cowley AW, Jr., Izumo S, Markham BE: Angiotensin II type 1a receptor gene expression in the heart: AP-1 and GATA-4 participate in the response to pressure overload. Proc Natl Acad Sci USA 1997;94:7543-8
59. Rao A, Luo C, Hogan PG: Transcription factors of the NFAT family: regulation and function. Annu Rev Immunol 1997;15:707-47